FDA Approves BLA761530 (LUMVOA) from Viridian Therapeutics
The FDA has approved BLA761530, known as LUMVOA, submitted by Viridian Therapeutics.
Asset / Drug
Drug and asset intelligence for BLA761530 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Monoclonal Antibody
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.